Suven Life Sciences surged 9.51% to Rs 138.70 after the firm dosed first subjects in a Phase-1 clinical trial of SUVN-I6107 being conducted in USA under FDA acceptance of investigational new drug (IND ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Suven Life Sciences Ltd. key Products/Revenue Segments include Sale of services for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, the company has reported a Consolidated Total Income ...

During the year under review, Company continued to advance its innovation on discovering and developing novel pharmaceutical products ... growth of the Company. Suven Life Employee Stock Option ...

Suven Pharma, Inc., in USA was originally formed by Suven Life Sciences Ltd while pursuing ... ANDAs of which 9 had received approvals and 8 products were launched up to March, 2022.During year ...

Suven Life Sciences (Suven) is a biopharmaceutical company. It carries out the discovery and development of novel pharmaceutical products. Its pipeline products include masupirdine (SUVN-502), ...

India-based Suven Life Sciences has announced the dosing of the first subjects in its Phase I clinical trial of SUVN-I6107 to ...

Examples of such Indian pharma companies are Zydus Lifesciences Ltd, Glenmark Pharma, Alembic Pharmaceuticals Ltd and Suven Life Sciences Limited. Zydus Lifesciences has established Zydus ...

Suven Life Sciences Ltd share price was up by 0.00% from the previous closing price of ₹127.92. Who are peers of Suven Life Sciences Ltd? The peers of Suven Life Sciences Ltd are Max Healthcare ...

Anthem Biosciences, a CRDMO specializing in drug discovery, development and manufacturing, has filed draft papers with Sebi for a ₹3,395 crore IPO. The IPO is an offer for sale by promoters, ...